2008-April Archives by Date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Tue Apr 1 05:56:01 2008
Ending: Wed Apr 30 15:16:02 2008
Messages: 160

• [Ip-health] WIPO press release: WIPO Member States Adopt 2008/09 Program and Budget   Thiru Balasubramaniam
• [Ip-health] WIPO Symposium on Public Policy Patent Landscaping in the Life Sciences: Provisional Program   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Gotham Prize Honors New Cancer Research   Thiru Balasubramaniam
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   B.Baker@neu.edu
• [Ip-health] Email alert: April issue of the WHO Bulletin   bulletin
• [Ip-health] =?WINDOWS-1252?Q?Patents_vs_Patients:_Cipla=92s_Victory_and_the_?= =?WINDOWS-1252?Q?Evolution_of_New_=93Compulsory_Licensing=94_Nor?= =?WINDOWS-1252?Q?ms?=   Judit Rius Sanjuan
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   mko
• [Ip-health] EU court says GSK must not refuse orders to combat parallel trading   robert weissman
• [Ip-health] =?windows-1252?Q?Haddad=3A_World_Watches_as_Indian_Hig?= =?windows-1252?Q?h_Court_Allows_Cipla_to_Market_=93Patented=94?= =?windows-1252?Q?_Cancer_Drug?=   robert weissman
• [Ip-health] Glaxo Violated EU Antitrust Law In Greece   Judit Rius Sanjuan
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   Miles Teg
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   michael.davis@law.csuohio.edu
• [Ip-health] Court rejects Patent Office's new rules, sides with GSK   robert weissman
• [thaifta] Re: [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   B.Baker@neu.edu
• [thaifta] Re: [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   Prof. Michael H. Davis
• [Ip-health] USTR Nat. Trade Barriers Report on Thai compulsory licenses   mko
• [Ip-health] Royalty rates and trade pressures.   James Love
• [Ip-health] Thai saga   Peter Drahos
• [Ip-health] Report: (unnamed) Indian official skeptical of CLs for export, cancer drugs   robert weissman
• [Ip-health] Thai saga   James Love
• [Ip-health] Pfizer response to Natco CL request   Judit Rius Sanjuan
• [Ip-health] Why is India not following Italy?   Sean Flynn
• [Ip-health] A document about EU vs Thailand and generics   =?ISO-8859-1?Q?J=E9r=F4me?= Martin
• [Ip-health] Denver Post: Rationing life-saving medicines in Thailand   Sarah Rimmington
• [Ip-health] Series on the WIPO Leadership Race Part IV - The North-South Question   Sisule Musungu
• [Ip-health] Re: [thaifta] A document about EU vs Thailand and generics   =?ISO-8859-1?Q?Ga=EBlle_Krikorian?=
• [Ip-health] Series on the WIPO Leadership Race Part IV - The North-South Question   Sisule F. Musungu
• [Ip-health] UFlorida story re UAEM chapter hosting AIDS-Free World's Stephen Lewis   Sarah Rimmington
• [Ip-health] McClatchy newswire: Thailand's ill see benefits from 'compulsory licensing'   Sarah Rimmington
• [Ip-health] Thai saga   Ken Shadlen
• [Ip-health] Thai saga   James Love
• [Ip-health] Slate on prizes and CLs   Amy Kapczynski
• [Ip-health] Gates grant requires broad dissemination of knowledge regarding influenza pandemics   James Love
• [Ip-health] Unions Pounce on Patent Reform   Sarah Rimmington
• [Ip-health] Slate on prizes and CLs   Aaron Shaw
• [Ip-health] USTR seeks to influence the position of the Indian Ministry of Health   Leena Menghaney
• [Ip-health] Bangkok Post: CL vital so long as healthcare lacks fund   Sarah Rimmington
• [Ip-health] WIPO draft patent landscaping report on neglected diseases   Thiru Balasubramaniam
• [Ip-health] Bank of Montreal - IMPORTANT MESSAGE   Bank of Montreal
• [Ip-health] European University Association recommends mandatory open access   Judit Rius Sanjuan
• [Ip-health] UK Govt creates life sciences marketing unit headed by AstraZeneca   Michelle Childs
• [Ip-health] Marcia Angell's 2001 call for clincial trial reform   James Love
• [Ip-health] Article on NCI-Sponsored Cancer Trials   James Love
• [Ip-health] Rising Prices & WTO + BIRD FLU + GMO Kit + Rural Job Scheme + IARI & Agri Education   Indian Society For Sustainable Agriculture
• [Ip-health] Democrats Urge Trade Ambassador to Focus on Access to Medicines   James Love
• [Ip-health] Democrats ask USTR to honor Doha Declaration   David Serafino
• [Ip-health] India's Dabur Pharma to provide generic anticancer injection to Thailand   Sarah Rimmington
• [Ip-health] Democrats Urge Trade Ambassador to Focus on Access to Medicines   Miles Teg
• [Ip-health] IP-Watch: WIPO Director General Candidates Prepare To Face Governments, NGOs   Thiru Balasubramaniam
• [Ip-health] Brazil declares Tenofovir of public interest   Judit Rius Sanjuan
• [Ip-health] Brazil declares Tenofovir of public interest   peter maybarduk
• [Ip-health] IHT: Thailand's health minister resigns over corruption scandal   Judit Rius Sanjuan
• [Ip-health] Prizes for drug development: Dr. Owell and James Love interviewed by Jean Marc Coicaud at the UN   James Love
• [Ip-health] USA: Co-Payments Go Way Up for Drugs With High Prices   Spring Gombe
• [Ip-health] News story on use of citizen petitions to FDA to delay generic entry   Mike Palmedo
• [Ip-health] EA GAM Bulletin: Thailand Lowers Medicine Prices; Faces U.S./E.U. Pressure   Sarah Rimmington
• [Ip-health] India: USTR pushes for drug data protection   Sarah Rimmington
• [Ip-health] Re: [Commons-Law] Symposium on the Challenges to =?iso-8859-1?Q?India=92s?= Patent Regime | NLSIU, Bangalore | April 12 & 13   Daya Shanker
• [Ip-health] African Civil Society Coalition on IGWG - statement to African Member States of WHO   Christa Cepuch
• [Ip-health] NYT - US - Co-Payments Soar for Drugs With High Prices   Miles Teg
• [Ip-health] Despite economic slowdown, healthcare CEO's bonuses are blooming   Miles Teg
• [Ip-health] Re: [Commons-Law] Symposium on the Challenges to =?iso-8859-1?Q?India=92s?= Patent Regime | NLSIU, Bangalore | April 12 & 13   denis
• [Ip-health] Democratic Candidates Compassion Forum on trade and access to medicines   Rohit Malpani
• [Ip-health] Series on the WIPO Leadership Race Part V- The Role and Influence of Non-Governmental Stakeholders   Sisule Musungu
• [Ip-health] National Academies report   Michael Selgelid
• [Ip-health] The Role of Prizes in Developing Low-Cost, Point-of-Care Rapid Diagnostic Tests and Better Drugs for Tuberculosis   James Love
• [Ip-health] Economist: Malaria and the politics of disease   Thiru Balasubramaniam
• [Ip-health] technical details IGWG IIbis meeting   Christian Wagner
• [Ip-health] MSD winds up Pakistan operations   Hafiz Aziz-ur- Rehman
• [Ip-health] Business Daily (Kenya): WHO talks on patents crucial (MSF)   Clio.VAN.CAUTER@geneva.msf.org
• [Ip-health] USD 1.5b package aims to boost supply of new vaccine   Adrienne.MacDONALD@geneva.msf.org
• [Ip-health] Mexican Senator: Mexico should grant CLs for 31 HIV/AIDS meds   peter maybarduk
• [Ip-health] AUTM asks members to sign IPI letter to IGWG, as part of pharmaceutical industry funded lobbying initative   James Love
• [Ip-health] Fwd: [HEALTHGAP] New Report: Scaling Up Access to Early InfantDiagnostics   Jean Blaylock
• [Ip-health] Mexican Senator: Mexico should grant CLs for 31 HIV/AIDS meds   K.Shadlen@lse.ac.uk
• [Ip-health] Forthcoming OECD study examines pharmaceutical pricing policies, pricing data, and innovation   Mike Palmedo
• [Ip-health] Speaking Tour by Dr Peter Mansfield, Director of Healthy Skepticism   Joana Ramos
• [Ip-health] AIDS Healthcare Foundation support for Mexican CL proposal   peter maybarduk
• [Ip-health] Barbados and Bolivia Submissions to the WHO/IGWG   james.love@keionline.org
• [Ip-health] Fourteenfold increase in price of epilepsy drug and Benefit Managers conflicts   James Love
• [Ip-health] University patent managers versus developing countries   james.love@keionline.org
• [Ip-health] Three letters to NYT on high co-payments article   James Love
• [Ip-health] Open Source software applications for health care   James Love
• [Ip-health] Comparative-Effectiveness Bill to Hit U.S. Senate   James Love
• [Ip-health] Indoor Tanning Industry Funded Author of NEJM Review On Vitamin D   Joana Ramos
• [Ip-health] JAPAN G8 PAPER FROM GLAXOSMITHKLINE   Peter Chowla
• [Ip-health] European Commission nominates high-level advisory group on research and science   Michelle Childs
• [Ip-health] Re: [Commons-Law] Symposium on the Challenges to India's Patent Regime | NLSIU, Bangalore   Shamnad Basheer
• [Ip-health] References from GSK G-8 document to IGWG   Thiru Balasubramaniam
• [Ip-health] Re: Three letters to NYT on high co-payments article   Joana Ramos
• [Ip-health] WHO IGWG negotiation: KEI comments on Global Strategy   Judit Rius Sanjuan
• [Ip-health] Australian Patent Law Litigation and Policy Debate   Matthew Rimmer
• [Ip-health] MSF's comments on the WHO draft global strategy and PoA on public health, innovation and intellectual property   Alexandra HEUMBER
• [Ip-health] WSJ: Inexact Copies: How Generics Differ From Brand Names   Matt Price
• [Ip-health] Global pharma =?UTF-8?B?4oCZcyBzdGFuZCBvbiBJbmRpYSBjb25zaWRlcmluZyBwZXJtaXRzIGZvcg==?= =?UTF-8?B?IGdlbmVyaWMgcHJvZHVjdGlvbiBvZiBwYXRlbnRlZCBkcnVncyBpcw==?= =?UTF-8?B?IGZsYXdlZA==?=   Ellen T HOEN
• [Ip-health] Brazilian MoH questions the constitutionnality of two articles that created the "pipeline" mechanism for patents application prior to the TRIPS agreement   MSF Michel Lotrowska
• [Ip-health] Brazil Declares Patented AIDS Drug Of Public Interest, Could Expand Access   Sarah Rimmington
• [Ip-health] The US prize for neglected diseases: the FDA priority review voucher   James Love
• [Ip-health] Ministerial Directive 681 - 8 April 2008 - Translation of tenofovir act that declares public interest for the analysis of tenofovir patent   MSF Michel Lotrowska
• [Ip-health] Indian Civil Society Statement on IGWG   Sarah Rimmington
• [Ip-health] Hank Grabowski on the priority review vouchers   James Love
• [Ip-health] UAEM Calls on AUTM to Retract Support of IPI Statement in Advance of IGWG   Ethan Guillen
• [Ip-health] support letter from Brazilian organizations and patients groups for IGWG   marcela.vieira@conectas.org
• [Ip-health] The future of US fast-track negotiating authority   Rohit Malpani
• [Ip-health] Bill Gates: "I think if you invent drugs, you should be able to charge for them"   James Love
• [Ip-health] Bill Gates: "I think if you invent drugs, you should be able to charge for them"   Prof. Michael H. Davis
• [Ip-health] Bill Gates:   Jeffrey A. Williams
• [Ip-health] Bill Gates:   michael.davis@law.csuohio.edu
• [Ip-health] Bill Gates:   Jeffrey A. Williams
• [Ip-health] Colombia: civil society groups file open license request for lopinavir+ritonavir (Kaletra)   peter maybarduk
• [Ip-health] AMC language in PEPFAR   James Love
• [Ip-health] Swiss and Thai NGOs urge the Swiss Government to respect Thailand's right to issue compulsory licences   Julien Reinhard
• [Ip-health] President of AUTM disassociates AUTM from IPI letter on IGWG   James Love
• [Ip-health] Launch of the African Copyright and Access to Knowledge Network (ACA2K)   Kawooya, Dick
• [Ip-health] Questioning the 1.5 billion dollar vaccine deal   Adrienne.MacDONALD@geneva.msf.org
• [Ip-health] Before his flip: Soderstrom backed the AUTM letter, aggressively   James Love
• [Ip-health] Comment on Thailand and USTR Special 301 Report: Outrageous, Cynical, Shameful - Again   robert weissman
• [Ip-health] Health GAP Comments on IGWG   B.Baker@neu.edu
• [Ip-health] Pharmalot: University Tech Managers & Affordable Medicine   Ethan Guillen
• [Ip-health] Prizes, etc, Maryam Hinds at the IGWG on the 2Bs proposals   James Love
• [Ip-health] Prizes, etc, Maryam Hinds at the IGWG on the 2Bs proposals   James Love
• [Ip-health] English translation: Colombian civil society groups file open license request for lopinavir+ritonavir (Kaletra)   peter maybarduk
• [Ip-health] German Bundestag on IGWG   Oliver Moldenhauer
• [Ip-health] Open licensing vs Monopoly Controlled Supply   James Love
• [Ip-health] The Health Impact Fund and open licensing vs. price controls   Aidan Hollis
• [Ip-health] WIPO's patent menu: Report on the International Patent System   Thiru Balasubramaniam
• [Ip-health] Signers of "Patient Declaration" for WHO talks financially tied to Big Pharma   Sarah Rimmington
• [Ip-health] Pharmalot: At WHO Meeting, Patient Group Has Pharma Ties   Sarah Rimmington
• [Ip-health] Eminent Academics: IGWG Delegates Should Explore New Mechanisms to Correct Current Deficiencies in Medicine System   Ethan Guillen
• [Ip-health] FT: Sacrificing at the altar of patents   Spring Gombe
• [Ip-health] MSF IGWG press release: critical stage for UN health summit   James ARKINSTALL
• [Ip-health] Webcast of Civil Society Meeting with WIPO DG candidates   Dalindyebo Bafana Shabalala
• [Ip-health] Medical R&D that Works for the Developing World   Sarah Rimmington
• [Ip-health] The Health Impact Fund and open licensing vs. price controls   James Love
• [Ip-health] FT: Sacrificing at the altar of patents   michael.davis@law.csuohio.edu
• [Ip-health] The Health Impact Fund and open licensing vs. price controls   Dean Baker
• [Ip-health] MSF Access Campaign new website   Laura.McCULLAGH@geneva.msf.org
• [Ip-health] The Times of India: "In defence of patents"   Malini Aisola
• [Ip-health] Latin Business Chronicle: Intellectual Property & Development   Malini Aisola
• [Ip-health] Essential Action Statement on IGWG   Sarah Rimmington
• [Ip-health] Wall Street Journal: Clinton Foundation, Unitaid Strike Deals on Price Cuts for AIDS Drugs   Thiru Balasubramaniam
• [Ip-health] IGWG Delegation Breakdown: Major Pharma and IP specialist presence   Suerie Moon
• [Ip-health] Patents as Barriers to Research   Sara Crager
• [Ip-health] Is greater patenting of research funded by taxpayers beneficial?   Gopa Kumar
• [Ip-health] Biotech Industry Organization IGWG delegation   Sarah Rimmington
• [Ip-health] Conflicts Clot HHS Cord Blood Stem Cell Committee   Joana Ramos
• [Ip-health] Microsoft Counsel an expert at WHO IGWG   Sarah Rimmington
• [Ip-health] PIJIP Snapshot of Industry Influence on the 2008 Special 301 Report   Mike Palmedo
• [Ip-health] Biotech Industry Organization IGWG delegation   robert weissman
• [Ip-health] Philippines Congress ratifies cheaper medicines bill   Rohit Malpani
• [Ip-health] NYT: Patent Law Battle a Boon to Lobbyists   Sarah Rimmington
• [Ip-health] Consideration of Elements 4.3(b) and (c ) at IGWG   Ethan Guillen
• [Ip-health] On Colombian delegation roleat IGWG   Francisco Rossi
• [Ip-health] Control of anticompetitive practices --- WHO vrs WIPO and WTO   James Love
• [Ip-health] Chris Israel: Another Bush Administration IP negotiators joins private sector   James Love
• [Ip-health] SUNS: Overhaul of health R&D & alert on WHO publications policy   Sangeeta
• [Ip-health] SPICY IP: Roche vs CIPLA: UK Rejects Tarceva as Too Expensive!!   James Love
• [Ip-health] Prizes and Parasites   Sara Crager
• [Ip-health] Partnership plans =?UTF-8?B?4oKsMmJuIGJvb3N0IGZvciBtZWRpY2FsIHJlc2VhcmNoLSBJbm5vdmF0aXZl?= =?UTF-8?B?IE1lZGljaW5lcyBJbml0aWF0aXZlIGEgcGFydG5lcnNoaXAgYmV0d2Vlbg==?= =?UTF-8?B?IEVDICYgRUZQSUE=?=   Alexandra HEUMBER
• [Ip-health] Element 7.3, the Global Research and Development Fund, has been opposed by high income countries   James Love

Last message date: Wed Apr 30 15:16:02 2008
Archived on: Wed Apr 30 14:16:03 2008

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...